SBI Securities »

Calidi Biotherapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $53 46 1.17
2025-09-30 $69 46 1.52

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Tesla Motors (TSLA)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
Alphabet Inc Class C cs (GOOG)
SPDR Gold MiniShares Trust Etf (GLDM)

View all positions for SBI Securities

Top funds holding Calidi Biotherapeutics

DRW Holdings
HighTower Advisors
Geode Capital Management
Vanguard Group
Virtu Financial
Rs Crum
Belpointe Asset Management
Northern Trust
Jane Street
Farther Finance Advisors
UBS Group
Tower Research Capital
Advisor Group Holdings
Finepoint Capital
Apollo Management Holdings

View all funds holding Calidi Biotherapeutics